Standard BioTools Inc.
LAB | NASDAQ
$0.74
-$0.03 (-3.87%)
At close: Sep 21, 2026, 4:00 PM ET
$0.73
-$0.01 (-1.35%)
Pre-market:
Sep 22, 2026, 4:00 AM ET
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | 100.31M | 127.07M | 19.28M | -34.69M | -33.46M | -26.03M | -34.07M | -26.94M | -45.72M | -32.16M | -19.78M | -21M | -17.04M | -16.84M | -20.85M | -29.43M | -63.54M | -76.29M | -9.43M | -13.84M | -17.14M | -18.82M |
Depreciation & Amortization | 2.68M | 1.41M | n/a | 5.59M | 3.99M | 4.17M | 3.95M | 3.86M | 3.86M | 5.19M | 3.91M | 3.99M | 3.63M | 3.66M | 3.82M | 3.81M | 4.05M | 3.97M | 4.08M | 4.09M | 3.9M | 3.92M |
Stock-Based Compensation | 12.87M | 8.82M | 5.74M | 7.54M | 5.37M | 9.01M | 7.47M | 5.92M | 6.73M | 3.57M | 3.48M | 3.39M | 3.11M | 3.15M | 1.68M | 4.49M | 4.66M | 4.04M | 4.36M | 4.32M | 3.74M | 3.68M |
Other Working Capital | -11.64M | -53.8M | -37.14M | 6.42M | -5.87M | -9.18M | -3.05M | -3.62M | -1.49M | -4.82M | 1.61M | 3.28M | 953K | 1.2M | -1.53M | 2M | -3.96M | 1.81M | -3.82M | -4.3M | 139K | -12.59M |
Other Non-Cash Items | -164.15M | -128.95M | 4.71M | 532K | 3.45M | -1.84M | -84K | -21K | 107K | -28.62M | 14.45M | 131K | 1.66M | 240K | -1.59M | 1.99M | 27.37M | 49.61M | -172K | -1.8M | 1.18M | 610K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -14.51M | 391K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -8.63M | -54.95M | -30.93M | -1.18M | -29K | -15.6M | 8.67M | -10.69M | -4.03M | -10.46M | -1.61M | 1.69M | -688K | 1.31M | -2.25M | -5.48M | -2.53M | 3.07M | -5.84M | -2.26M | -6.34M | -2.28M |
Operating Cash Flow | -56.91M | -46.6M | -1.2M | -22.2M | -20.67M | -30.28M | -14.06M | -27.87M | -39.05M | -62.48M | -14.06M | -11.41M | -9.33M | -8.49M | -19.18M | -24.61M | -29.99M | -15.59M | -7M | -9.49M | -14.66M | -12.9M |
Capital Expenditures | -914K | -570K | -476K | -886K | -1.89M | -5.05M | -3.38M | -2.26M | -1.94M | -781K | -78K | -905K | -838K | -1.01M | -755K | -1.26M | -938K | -868K | -463K | -1.71M | -4.17M | -6.92M |
Cash Acquisitions | n/a | 363.22M | n/a | n/a | n/a | n/a | -1.39M | n/a | n/a | 280.03M | 13.04M | n/a | n/a | -44.16M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -237.89M | -186.56M | -30.21M | n/a | n/a | -32.32M | n/a | -78.63M | -74.81M | n/a | -39.04M | -49.02M | n/a | -6.84M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | 53M | 15M | 25M | n/a | n/a | 52M | n/a | 50M | 127M | n/a | 26M | n/a | n/a | 51M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | 391.3M | n/a | -5M | -5.8M | 29.39M | n/a | 30.49M | n/a | n/a | 38.82M | -13.04M | n/a | 40.96M | 44.16M | 41M | 12M | -137.3M | n/a | -682K | n/a | n/a | 2M |
Investing Cash Flow | 205.5M | 191.09M | -10.68M | -6.68M | 27.51M | 14.63M | 25.73M | -30.88M | 50.26M | 318.08M | -13.12M | -49.93M | 40.13M | 43.15M | 40.25M | 10.74M | -138.24M | -868K | -1.15M | -1.71M | -4.17M | -4.92M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | -55M | n/a | n/a | -8.19M | -1.25M | -833K | n/a | n/a | n/a | n/a | n/a | 18.16M | n/a | n/a | n/a | -501K |
Common Stock Repurchased | n/a | n/a | n/a | -112K | -200K | -46K | -45K | n/a | -29.44M | -11.07M | -174K | -399K | -2.41M | -2.47M | -593K | -102K | 8K | -87K | -98K | -144K | n/a | -525K |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -256K | -118K | -126K | n/a | 308K | n/a | 525K | -70K | 1.08M | -473K | 421K | 68K | 326K | -92K | 323K | 97K | 212.95M | -87K | 7.4M | 9.97M | -1.03M | n/a |
Financial Cash Flow | -178K | -40K | 620K | -112K | 108K | -46K | -54.52M | -2K | -28.36M | -19.73M | -1M | -1.16M | -2.08M | -2.56M | -270K | -5K | 212.96M | 18.08M | 7.3M | 9.82M | -133K | -1.03M |
Net Cash Flow | 148.82M | 144.57M | -11.36M | -29.2M | 7.73M | -15.35M | -43.12M | -59.16M | -17.24M | 235.85M | -27.95M | -62.65M | 28.64M | 32.13M | 21.11M | -14.16M | 44.38M | 1.53M | -858K | -1.55M | -18.88M | -18.78M |
Free Cash Flow | -57.82M | -47.17M | -1.67M | -23.09M | -22.56M | -35.34M | -17.44M | -30.12M | -40.99M | -63.26M | -14.14M | -12.32M | -10.17M | -9.5M | -19.94M | -25.88M | -30.93M | -16.46M | -7.47M | -11.2M | -18.84M | -19.82M |
Adj. Free Cash Flow | -70.7M | -55.99M | -7.42M | -30.62M | -27.93M | -44.35M | -24.91M | -36.05M | -47.72M | -66.83M | -17.61M | -15.7M | -13.28M | -12.64M | -21.62M | -30.37M | -35.59M | -20.5M | -11.83M | -15.52M | -22.58M | -23.5M |
Maintenance CapEx | -914K | -570K | -476K | -886K | -1.89M | -5.05M | n/a | n/a | -1.94M | n/a | n/a | -905K | n/a | -1.01M | -755K | -1.26M | -938K | -868K | -463K | -1.71M | -3.04M | -5.74M |
Growth CapEx | n/a | n/a | n/a | n/a | n/a | n/a | -3.38M | -2.26M | n/a | -781K | -78K | n/a | -838K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -1.13M | -1.18M |
Owner Earnings | -57.82M | -47.17M | -1.67M | -23.09M | -22.56M | -35.34M | -14.06M | -27.87M | -40.99M | -62.48M | -14.06M | -12.32M | -9.33M | -9.5M | -19.94M | -25.88M | -30.93M | -16.46M | -7.47M | -11.2M | -17.71M | -18.65M |
Add to Watchlist
Select watchlists to add or remove LAB